SEC Tracker
Get the app

Halozyme Therapeutics HALO

Torley Helen (President, CEO, Director) plans to sell 136,569 HALO shares, about $10M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Oct 1, 2025
  2. Broker: J.P. Morgan Securities LLC
  3. Shares acquired by: Stock Option Exercise
  4. 10b5-1 plan adopted: Mar 21, 2025

All of Torley Helen's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 11,705 shares at $75.11 on Oct 1, 2025 · Form 4
  • Sold 8,295 shares at $75.69 on Oct 1, 2025 · Form 4
  • Sold 6,600 shares at $70.51 on Oct 2, 2025 · Form 4
  • Sold 10,200 shares at $71.28 on Oct 2, 2025 · Form 4
  • Sold 2,400 shares at $72.07 on Oct 2, 2025 · Form 4
  • Sold 700 shares at $73.24 on Oct 2, 2025 · Form 4
  • Sold 100 shares at $74.67 on Oct 2, 2025 · Form 4
  • Sold 14,235 shares at $68.47 on Oct 3, 2025 · Form 4
  • Sold 2,334 shares at $69.83 on Oct 3, 2025 · Form 4
  • Sold 2,707 shares at $70.58 on Oct 3, 2025 · Form 4
  • Sold 724 shares at $71.67 on Oct 3, 2025 · Form 4
  • Sold 19,900 shares at $68.71 on Nov 10, 2025 · Form 4
  • Sold 100 shares at $69.3 on Nov 10, 2025 · Form 4
  • Sold 4,500 shares at $67.89 on Nov 11, 2025 · Form 4
  • Sold 4,000 shares at $68.8 on Nov 11, 2025 · Form 4
  • Sold 11,500 shares at $69.73 on Nov 11, 2025 · Form 4
  • Sold 12,718 shares at $70.22 on Nov 12, 2025 · Form 4
  • Sold 6,784 shares at $71.09 on Nov 12, 2025 · Form 4
  • Sold 498 shares at $71.67 on Nov 12, 2025 · Form 4
  • Sold 10,406 shares at $68.51 on Dec 1, 2025 · Form 4
  • Sold 5,402 shares at $69.44 on Dec 1, 2025 · Form 4
  • Sold 500 shares at $70.36 on Dec 1, 2025 · Form 4
  • Sold 261 shares at $71.6 on Dec 1, 2025 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Halozyme Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Axsome Therapeutics AXSM public float $4.4B, Jun 30, 2025
  2. Alkermes ALKS public float $4.7B, Jun 30, 2025
  3. Lantheus Holdings LNTH public float $4.3B, Jun 30, 2025
  4. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  5. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.